Investigating the link between sexually transmitted infections and female infertility
Official title: Epidemiology of Sexually Transmitted Infections and Its iMpAcT on fEmale Infertility
Run by University of Luebeck · NCT05244967 · Data updated 2026-11-12
This study is trying to see if sexually transmitted infections affect fertility in young women aged 18-22 by looking at their vaginal health over time.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 22 Years |
| Sex | Women only |
| Enrollment | 533 (estimated) |
| Sponsor | University of Luebeck Academic / other |
| Locations | 1 site (Lübeck) |
| Status | Recruiting |
| Started | November 11, 2020 |
| Main results expected | December 31, 2028 |
| Study ends | June 30, 2029 |
| Registry record updated | April 30, 2026 |
| Trial ID | NCT05244967 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are young women aged 18-22 who can provide informed consent.
✕Probably not a fit
Patients who are pregnant, sterilized, or unable to give informed consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to explore the prevalence of sexually transmitted infections (STIs) among young women aged 18-22 and assess how the female genital tract microbiome may influence fertility. Participants will undergo vaginal swab testing to collect data on STIs and microbiome composition. The study will follow a longitudinal approach to gather comprehensive insights over time, focusing on the relationship between STIs and infertility outcomes.
Why it matters
Potential benefit: If successful, this study could enhance understanding of how STIs affect female fertility, leading to better prevention and treatment strategies.
How similar studies have gone: While there have been studies on STIs and fertility, this specific focus on the microbiome's role is relatively novel and may provide new insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18-22 years * informed consent Exclusion Criteria: * pregnancy * sterilization * not capable of giving informed consent
Where it's running
-
Klinik für Infektiologie und Mikrobiologie
Lübeck, Germany Recruiting
Study contacts
- Study coordinator: Nadja Käding, Dr.
- Email: nadja.kaeding@uksh.de
- Phone: +4945131019010
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Point-of-care STI testing to speed treatment in pregnant patients
This study tests whether rapid point-of-care STI tests in pregnant women at Grady Memorial Hospital can speed up treatment for syphilis, chlamydia, gonorrhea, and trichomonas compared with standard lab testing.
-
New ALPCO blood tests to detect syphilis antibodies
This will test two ALPCO blood tests that look for treponemal and non-treponemal antibodies in people screened for or suspected of having syphilis, including pregnant and HIV-positive individuals.
-
Shamba Maisha: a household farming program to improve sexual and reproductive health for adolescent girls and young women in Western Kenya
This project will try a household-level agricultural program (Shamba Maisha) with adolescent girls and young women (ages 15–19) and their caregivers in Western Kenya to see if improving food security reduces HIV and other STI risk and improves reproductive and mental health.
-
Assessing Mycoplasma genitalium infection in men who have sex with men in Hong Kong
This study is trying to understand how common Mycoplasma genitalium infections are among men who have sex with men in Hong Kong and how they spread, by having participants fill out surveys and provide samples for testing.
-
Understanding antibiotic resistance and microbiome changes in STI prevention
This study is trying to see how using doxycycline for STI prevention affects antibiotic resistance and changes in gut bacteria in men who have sex with men.
-
Doxycycline to prevent bacterial STIs in sexual and gender minorities in Rio de Janeiro.
This research will try taking doxycycline after sex to see if it lowers the chance of syphilis, gonorrhea, and chlamydia for men who have sex with men, transgender women, and travestis in Rio de Janeiro who are living with HIV or using PrEP.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.